XML 42 R26.htm IDEA: XBRL DOCUMENT v3.25.3

Segmented Information (Tables)

12 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Schedule of summarizes the significant expenses

Schedule of summarizes the significant expenses
		2025				2024				2023
Research and development costs
Preclinical studies		$	543			$	663			$	627
Clinical trials			15,805				21,301				21,873
Personnel costs			13,466				13,676				10,264
Non-cash share-based compensation			7,013				5,813				10,812
Other research and development costs(a)			765				385				141
Total research and development costs			37,592				41,838				43,717
General and administrative costs
Personnel costs			2,288				2,177				2,527
Non-cash share-based compensation			4,536				3,625				5,558
Other general and administrative costs(b)			6,992				5,237				3,961
Total general and administrative costs			13,816				11,039				12,046
Other income			5,031				9,875				8,258
Net loss		$	(46,377	)		$	(43,002	)		$	(47,505	)

(a) Other research and development costs include, but are not limited to, publications, sponsorships, membership fees, scientific conferences, and medical affairs strategy and branding.

(b) Other general and administrative expenses include, but are not limited to, office rent, public company reporting requirements including professional fees, insurance, and other general operating expenses not otherwise included in research and development expenses.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration